November 2016 Slide of the Month

screen-shot-cirs_nov_2016_slide_of_the_monthNew economies: Scenarios with a likelihood >50% and impact

Results from 2015 CIRS Focus Study: Strategies, enablers and barriers to medicines development in the Emerging Markets: The 2025 global regulatory landscape.

Scenarios rated by international pharmaceutical industry respondents as having a 50% or greater likelihood of occurring in jurisdictions with emerging economies and the impact of those scenarios on the regulatory landscape.

Scenarios labelled with the letter A= alignment initiatives; P= process initiatives; T= new technologies.

Download this slide